Qitao Yu Selected Research

Qitao Yu Research Topics

Disease

19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 08/2005
16	Neoplasms (Cancer) 02/2024 - 08/2005
6	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2019
4	Disease Progression 01/2023 - 12/2019
2	Adenocarcinoma of Lung 01/2023 - 01/2020
1	Brain Neoplasms (Brain Tumor) 02/2024
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2023
1	Exanthema (Rash) 10/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Nasopharyngeal Carcinoma 12/2021
1	Infections 01/2021
1	Pulmonary Hypertension 01/2021
1	Pain (Aches) 01/2021
1	Pericardial Effusion 01/2021
1	Proteinuria 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 11/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Thymoma (Thymic Carcinoma) 11/2015
1	Myasthenia Gravis 11/2015
1	HIV Infections (HIV Infection) 11/2002

Drug/Important Bio-Agent (IBA)

6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2018
5	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2021
4	LigandsIBA 02/2024 - 01/2021
4	Programmed Cell Death 1 ReceptorIBA 02/2024 - 01/2021
4	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2020
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2002
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2021
3	Alanine Transaminase (SGPT)IBA 10/2023 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 01/2018
2	tislelizumabIBA 02/2024 - 12/2023
2	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2020
2	aflutinibIBA 01/2023 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2021
2	AlbuminsIBA 01/2020 - 01/2020
2	Alkaline PhosphataseIBA 01/2020 - 01/2020
2	Bevacizumab (Avastin)FDA Link 12/2019 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 08/2005
1	Apoptosis Regulatory ProteinsIBA 02/2024
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2024
1	CrizotinibIBA 01/2023
1	darifenacin FDA Link 10/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2022
1	PlatinumIBA 01/2022
1	AfatinibIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	camrelizumabIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 10/2020
1	alectinibIBA 01/2020
1	Monoclonal AntibodiesIBA 12/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2019
1	Biosimilar PharmaceuticalsIBA 12/2019
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	nedaplatinIBA 11/2018
1	Docetaxel (Taxotere)FDA Link 11/2018
1	wogonosideIBA 10/2018
1	Long Noncoding RNAIBA 01/2015
1	EndostatinsIBA 08/2005
1	thiamine triphosphorate (TTP)IBA 08/2005
1	VaccinesIBA 11/2002

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 02/2024 - 08/2005
7	Therapeutics 01/2023 - 01/2018
4	Immunotherapy 08/2023 - 01/2021
1	Plasmapheresis 11/2015
1	Radiotherapy 11/2015
1	Ligation 11/2002